A BILL 
To amend the United States-Mexico Border Health Commis-
sion Act, with respect to preparedness for COVID–19 
and other infectious diseases in the border region, and 
for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Binational Health 
4
Strategies Act of 2021’’. 
5
04:02 Apr 19, 2021
H1538
2 
•HR 1538 IH
SEC. 2. UNITED STATES-MEXICO BORDER HEALTH COMMIS-
1
SION INFECTIOUS DISEASE PREPAREDNESS. 
2
The United States-Mexico Border Health Commis-
3
sion Act (22 U.S.C. 290n et seq.) is amended by inserting 
4
after section 4 (22 U.S.C. 290n–2) the following: 
5
‘‘SEC. 4A. INFECTIOUS DISEASE PREPAREDNESS. 
6
‘‘(a) PRESIDENTIAL NEGOTIATIONS.—The President 
7
is authorized and directed to, not later than 30 days after 
8
the date of the enactment of this section, seek to begin 
9
negotiations with Mexico to amend the agreement entered 
10
into pursuant to section 2, addressing infectious disease 
11
preparedness in the United States-Mexico Border Area, 
12
with respect to— 
13
‘‘(1) COVID–19, including the development of 
14
the report specified in subsection (b) and the plan 
15
specified in subsection (c); and 
16
‘‘(2) other infectious diseases, including the de-
17
velopment and implementation of the plan specified 
18
in subsection (d). 
19
‘‘(b) COVID–19 RESPONSE.—Not later than 120 
20
days after the date on which negotiations referred to in 
21
subsection (a) begin, and annually thereafter (for as long 
22
as the Commission, acting with the participation of mem-
23
bers representing both the United States and Mexican sec-
24
tions, determines is necessary), the Commission shall sub-
25
mit to Congress a report on the United States-Mexico Bor-
26
04:02 Apr 19, 2021
H1538
3 
•HR 1538 IH
der Area’s response (beginning on February 1, 2020) to 
1
COVID–19, including with respect to testing, contact trac-
2
ing, and other infection prevention and control measures 
3
carried out in the United States-Mexico Border Area, in 
4
both the United States and Mexico. 
5
‘‘(c) COVID–19 BINATIONAL PLAN.— 
6
‘‘(1) IN
GENERAL.—Not later than 60 days 
7
after the date on which negotiations referred to in 
8
subsection (a) begin, the Commission (acting with 
9
the participation of members representing both the 
10
United States and Mexican sections) shall develop, 
11
and publish on a public website of the Commission, 
12
a binational strategic plan that addresses, with re-
13
spect to COVID–19, how— 
14
‘‘(A) the United States-Mexico Border 
15
Area should strengthen its response to COVID– 
16
19, with a focus on testing, contact tracing, and 
17
other infection prevention and control measures; 
18
‘‘(B) the effect of COVID–19 on the eco-
19
nomic conditions in the United States-Mexico 
20
Border Area may be mitigated; 
21
‘‘(C) the sharing of relevant health data, 
22
with respect to COVID–19, including testing 
23
and positivity rates, between health agencies 
24
04:02 Apr 19, 2021
H1538
4 
•HR 1538 IH
within the United States-Mexico Border Area 
1
can be strengthened; and 
2
‘‘(D) a COVID–19 vaccine should be dis-
3
bursed throughout the United States-Mexico 
4
Border Area, taking into account the various 
5
vulnerable populations in the region. 
6
‘‘(2) IMPLEMENTATION.—Not later than 90 
7
days after the date on which negotiations referred to 
8
in subsection (a) begin, the Commission (acting with 
9
the participation of members representing both the 
10
United States and Mexican sections) shall develop, 
11
and publish on a public website of the Commission, 
12
what actions Federal agencies will take within the 
13
United States section and agencies of the Govern-
14
ment of Mexico will take within the Mexican section 
15
of the United States-Mexico Border Area to facili-
16
tate implementation of the plan under paragraph 
17
(1). At least once each year after the publication of 
18
such information, the Commission shall submit to 
19
Congress a report on actions taken by Federal agen-
20
cies and agencies of the Government of Mexico to fa-
21
cilitate that implementation during the year covered 
22
by the report. 
23
‘‘(d) FUTURE INFECTIOUS DISEASE PLAN.— 
24
04:02 Apr 19, 2021
H1538
5 
•HR 1538 IH
‘‘(1) IN GENERAL.—Not later than 180 days 
1
after the date on which negotiations referred to in 
2
subsection (a) begin, the Commission shall develop 
3
and publish a plan to prepare and respond to infec-
4
tious diseases (other than COVID–19) within the 
5
United States-Mexico Border Area. Such plan shall 
6
address how— 
7
‘‘(A) the United States-Mexico Border 
8
Area should strengthen its response to such in-
9
fectious diseases, with a focus on testing, con-
10
tact tracing, and other infection prevention and 
11
control measures; 
12
‘‘(B) the effect of such infectious diseases 
13
on the economic conditions in the United 
14
States-Mexico Border Area may be mitigated; 
15
‘‘(C) the sharing of relevant health data, 
16
with respect to such infectious diseases, includ-
17
ing testing and positivity rates, between health 
18
agencies within the United States-Mexico Bor-
19
der Area can be strengthened; and 
20
‘‘(D) a vaccine for such infectious diseases 
21
should be disbursed throughout the United 
22
States-Mexico Border Area, taking into account 
23
the various vulnerable populations in the region. 
24
04:02 Apr 19, 2021
H1538
6 
•HR 1538 IH
‘‘(2) UPDATES.—The Commission shall update 
1
the plan published under paragraph (1) at least once 
2
every 3 years for as long as the Commission, acting 
3
with the participation of members representing both 
4
the United States and Mexican sections, determines 
5
is necessary. 
6
‘‘(3) IMPLEMENTATION.—Not later than 210 
7
days after the date on which negotiations referred to 
8
in subsection (a) begin, the Commission (acting with 
9
the participation of members representing both the 
10
United States and Mexican sections) shall develop, 
11
and publish on a public website of the Commission, 
12
what actions Federal agencies will take within the 
13
United States section and agencies of the Govern-
14
ment of Mexico will take within the Mexican section 
15
of the United States-Mexico Border Area to facili-
16
tate implementation of the plan under paragraph 
17
(1). At least once a year after the publication of 
18
such information, the Commission shall submit to 
19
Congress a report on actions taken by Federal agen-
20
cies and agencies of the Government of Mexico to fa-
21
cilitate that implementation during the year covered 
22
by the report. 
23
‘‘(e) DEFINITIONS.—In this section: 
24
04:02 Apr 19, 2021
H1538
7 
•HR 1538 IH
‘‘(1) COVID–19.—The term ‘COVID–19’ re-
1
fers to the 2019 coronavirus disease caused by 
2
SARS–CoV–2. 
3
‘‘(2) SARS–COV–2.—The term ‘SARS–CoV–2’ 
4
refers to the severe acute respiratory syndrome 
5
coronavirus 2 virus responsible for COVID–19 and 
6
includes any viral variant mutating therefrom with 
7
pandemic potential.’’. 
8
Æ 
04:02 Apr 19, 2021
H1538
